J B Chemicals & Pharmaceuticals Ltd

J B Chemicals & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

J B Chemicals & Pharmaceuticals Ltd has reached a significant milestone by hitting a new 52-week high of Rs.2171.4 today, marking a notable achievement in its stock performance amid a challenging broader market environment.

J B Chemicals & Pharmaceuticals Ltd has reached a significant milestone by hitting a new 52-week high of Rs.2140.25 today, marking a notable achievement in its stock performance amid a challenging broader market environment.

J B Chemicals & Pharmaceuticals Ltd has reached a significant milestone by hitting a new 52-week high of Rs.2129.9 today, marking a notable achievement in its stock performance amid a challenging broader market environment.

J B Chemicals & Pharmaceuticals Ltd has reached a significant milestone by hitting a new 52-week high of Rs. 2119.85 on 10 Mar 2026, marking a notable surge in its stock price amid a mixed market environment.

J B Chemicals & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with the latest insights into its performance and outlook.

J B Chemicals & Pharmaceuticals Ltd has reached a significant milestone by hitting a new 52-week high of Rs.2112.55 today, marking a continuation of its strong upward momentum in the Pharmaceuticals & Biotechnology sector.

J B Chemicals & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 February 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance.

J B Chemicals & Pharmaceuticals Ltd has reached a significant milestone by hitting a new 52-week high of Rs.2087.2 today, marking a notable achievement in its stock performance amid a positive market environment.

J B Chemicals & Pharmaceuticals Ltd has reached a significant milestone by hitting a new 52-week high of Rs.2067.1 today, marking a notable achievement in its stock performance amid a mixed market environment.

J B Chemicals & Pharmaceuticals Ltd has reached a significant milestone by hitting a new 52-week high of Rs.2020.5 today, marking a notable achievement in its stock performance amid a broadly positive market environment.

J B Chemicals & Pharmaceuticals Ltd has reached a significant milestone by hitting a new 52-week high of Rs.2014.1 today, reflecting strong momentum in the Pharmaceuticals & Biotechnology sector amid mixed market conditions.

J B Chemicals & Pharmaceuticals Ltd has exhibited a notable shift in technical momentum, transitioning from a mildly bullish stance to a more assertive bullish trend. This change is underscored by strong signals from key technical indicators including MACD, Bollinger Bands, and moving averages, suggesting an increasingly positive outlook for the stock amid a robust price rally.

J B Chemicals & Pharmaceuticals Ltd has reached a significant milestone by hitting a new 52-week high of Rs. 2000.9, marking a notable surge in the stock’s performance amid a mixed market backdrop. This achievement underscores the company’s sustained momentum within the Pharmaceuticals & Biotechnology sector.

J B Chemicals & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 15 February 2026, providing investors with the latest insights into its performance and outlook.

J B Chemicals & Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock continues to demonstrate resilience with mixed signals from key technical indicators such as MACD, RSI, and moving averages. This analysis delves into the evolving technical landscape, price momentum, and comparative performance against the Sensex to provide investors with a comprehensive view of the stock’s current positioning.

J B Chemicals & Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of early February 2026. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock continues to demonstrate resilience with mixed signals from key technical indicators such as MACD, RSI, and moving averages, reflecting a complex market sentiment within the Pharmaceuticals & Biotechnology sector.